Human Growth Hormone (HGH) Market is growing at a Highest CAGR of 6.8% with Top Players – Pfizer, AnkeBio, EMD Serono, F Hoffmann-La Roche, Ferring BV, Eli Lilly, Teva Pharmaceutical | Foreseen Till 2024

Global Human Growth Hormone (HGH) Market Report 2019 offers elaborated knowledge on the market parts like size, Key Regions, growth, trends, dominating firms, Major Manufactures. The Human Growth Hormone (HGH) report introduces market competition situation among the vendors, revenue, product & services, latest developments and business strategies.

Overview of the Global Human Growth Hormone (HGH) Market:

The report spread across 110 pages is an overview of the Global Human Growth Hormone (HGH) Market. These report study based on the Human Growth Hormone (HGH) Market. It is a complete overview of the market, covering various aspects prevailing market landscape. It accumulates comprehensive information and research methodologies.

The Global Human Growth Hormone (HGH) Market is expected to register a CAGR of 6.8% during the forecast period (2014 - 2024). The human growth hormone, also somatotropin, is a peptide hormone that helps to stimulate growth, cell regeneration, and cell reproduction.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/19718 .

The increase in applications of growth hormone and the awareness about the effects of growth hormone in the treatment of short stature are major factors propelling the growth of this market. Most of the companies are investing in R&D for developing a growth hormone that has fewer side effects and will be long-acting hormonal therapy. Technical developments in the recombinant human growth hormone are also expected to boost the growth of the human growth hormone market over the forecast period.

Industry Updates:

Pfizer manages its commercial operations through two distinct business segments Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH segment focuses on developing, manufacturing and commercializing novel, value-creating medicines, and vaccines while EH segment includes the legacy brands that have lost or will soon lose market exclusivity in both emerging and developed markets. Pfizer’s HGH product Genotropin comes under rare disease division in IH segment. In the year 2017, Genotropin contributed to revenue of USD 532 million, which is about 24% of the revenues of the Rare Disease division. In the year 2016, somatrogon (hGH-CTP) a prospective long-acting HGH drug failed to achieve a satisfactory result in its ongoing phase III trial in adult patients. HGH-CTP was being jointly developed by Pfizer and Opko Health, Inc and was previously forecasted as a blockbuster product.

Regionally, North America to Dominate the Human Growth Hormone (HGH) Market; The United States accounted for the largest market share. The dominance of this country can be attributed to factors, such as high healthcare expenditure, the high prevalence of target diseases, and the availability of reimbursements. In the United States, approximately one in 4,000 to 10,000 children suffer from growth hormone deficiency and approximately 50,000 adults have growth hormone deficiency, with about 6,000 new adult patients diagnosed every year.

Purchase this report online with 110 Pages, Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/19718 .

Major Key Players:

1 AnkeBio Co. Ltd

2 EMD Serono Inc.

3 F. Hoffmann-La Roche

4 Ferring BV

5 Ipsen

6 Eli Lilly and Company

7 Novo Nordisk A/S

8 Pfizer Inc

9 Teva Pharmaceutical Industries Ltd and More……………..

Request a Discount on standard prices of this premium report @ https://marketprognosis.com/discount-request/19718 .

This study answers to the below key questions:

1 What will the market size be in 2024 and what will the growth rate be?

2 What are the key market trends?

3 What are the challenges to market growth?

4 Who are the key players in this market?

5 What are the market opportunities and threats faced by the key players?

Table of Contents:

1 Introduction

2 Global Human Growth Hormone (HGH) Market Research Methodology

3 Executive Summary

4 Global Human Growth Hormone (HGH) Market Dynamics

5 Global Human Growth Hormone (HGH) Market Segmentation

6 Competitive Landscape

7 Global Human Growth Hormone (HGH) Market Opportunities and Future Trends

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMark Pvt. Ltd.

Thane – 421501

India.

sales@marketprognosis.com

+1 973 241 5193

https://www.marketprognosis.com

This release was published on openPR.